Getein Introduces New MAGICL 6000 Chemiluminescence Immunoassay Analyzer at MEDICA 2022
|
By HospiMedica International staff writers Posted on 13 Nov 2022 |
|
Getein Biotech, Inc. (Nanjing, China) is introducing new POC solutions, including analyzers and rapid tests, at the 2022 edition of MEDICA, the world's largest trade fair for medical technology, being held from 14 to 17 November in Düsseldorf, Germany.
At MEDICA 2022, Getein is introducing MAGICL 6000, a compact and innovative chemiluminescence immunoassay analyzer, with optimal choice for mid to high-workflow laboratories that require a one-step chemiluminescence solution. Highly productive and compact, the instrument enables fully automated operation and provides the fastest testing speed of any device of its size. Getein is also showcasing Metis 600, a bench-top two in one immuno-hemanalysis and hematology modular system.
Among its range of POC platforms being highlighted at the event is the Getein 1600 fully-automated immunofluorescence quantitative analyzer which combined with bar-coded, ready-to-use strip cassettes, delivers accurate testing results in minutes. In conjunction with dedicated immunofluorescence test kits, the Getein 1600 automates the detection and quantification of markers for cardiovascular disease, renal diseases, inflammation, fertility, diabetes mellitus, bone metabolism, tumor and thyroid in a biological sample. Visitors to the company’s booth at MEDICA 2022 can also experience the Getein 1180 immunofluorescence quantitative analyzer that is used to measure the concentration of biomarkers in human whole blood, serum, plasma, urine, nasal swab, or saliva samples. The results can be used as an aid in clinical diagnosis of laboratory and POC testing and is applicable in emergency departments, clinical labs, outpatient departments, ICU, CCU, cardiology, ambulance, inpatient wards, etc.
Also on display at MEDICA 2022 are the Getein 1160 multi-channel POCT analyzer which has four incubation channels and one emergency test channel, along with a constant test environment with 32℃ to ensure more accurate test results. The Getein 1160 is applicable in emergency departments, clinical labs, outpatient departments, ICU, CCU, cardiology, ambulance, inpatient wards, etc. Alongside the Getein 1160, the company is demonstrating the Getein 208 hand-held integrated system that works with dedicated test kits made by Getein. Getein 208 is intended to detect and quantify specific chemical components in human blood serum, plasma, whole blood, capillary blood and urine samples through dry chemistry and fluorescence immunoassay. Getein is also showcasing rapid tests at MEDICA 2022, including its Monkeypox Virus Real-time PCR Kit which is used for the qualitative detection of MPV in serum or lesion exudate samples.
Related Links:
Getein Biotech, Inc.
Latest MEDICA 2022 News
- Fisher & Paykel Highlights Innovative Products for Respiratory Care at MEDICA 2022
- Huntleigh Exhibits Range of Vital Signs Monitoring Solutions at MEDICA 2022
- Owen Mumford Presents Cutting-Edge Capillary Blood Sampling Devices for POC Testing
- Noul Demonstrates AI-Driven On-Site Diagnostics Platform at MEDICA 2022
- KUKA Presents Robot-Based Assistance Systems at MEDICA 2022
- Heyer Medical Exhibits State-Of-The-Art Ventilators, Anesthesia Workstations and Surgical Lights
- Progetti Highlights Advanced Defibrillators for Emergency Medicine at MEDICA 2022
- LG Electronics Showcases State-Of-The-Art Surgical, Diagnostic and Clinical Monitors at MEDICA 2022
- World’s First Detachable 4K 8MP Handheld Camera for Telemedicine Showcased at MEDICA 2022
- EIZO Exhibits Complete New CuratOR Series of Surgical Monitors at MEDICA 2022
- Parker Labs Showcases Range of Ultrasound Equipment Cleaners and Disinfectants
- OptoMedic Demonstrates Range of Endoscopic Imaging Systems at MEDICA 2022
Channels
Artificial Intelligence
view channel
AI-Powered Algorithm to Revolutionize Detection of Atrial Fibrillation
Atrial fibrillation (AFib), a condition characterized by an irregular and often rapid heart rate, is linked to increased risks of stroke and heart failure. This is because the irregular heartbeat in AFib... Read more
AI Diagnostic Tool Accurately Detects Valvular Disorders Often Missed by Doctors
Doctors generally use stethoscopes to listen for the characteristic lub-dub sounds made by heart valves opening and closing. They also listen for less prominent sounds that indicate problems with these valves.... Read more
Critical Care
view channel
Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more
Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
Patients suffering from rare diseases often endure extensive delays in receiving accurate diagnoses and treatments, which can lead to unnecessary tests, worsening health, psychological strain, and significant... Read more
On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
A team of researchers at the University of Missouri (Columbia, MO, USA) has achieved a milestone in developing a state-of-the-art on-skin wearable bioelectronic device. This development comes from a lab... Read more
First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
Peripheral artery disease (PAD) affects millions and presents serious health risks, particularly its severe form, chronic limb-threatening ischemia (CLTI). CLTI develops when arteries are blocked by plaque,... Read moreSurgical Techniques
view channel
Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
Grade III or IV gliomas are among the most common and deadly brain tumors, with around 20,000 cases annually in the U.S. and 1.2 million globally. These tumors are very aggressive and tend to infiltrate... Read more.jpg "Image: The robotic bronchial endoscope system is designed to treat individuals with obstructed airways (Photo courtesy of KIMM)")
Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
A novel robotic bronchial endoscopic system has been developed to minimize side effects and provide timely intervention for airway obstructions caused by food or foreign bodies in infants, young children,... Read more
Patient Care
view channel
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read more
Health IT
view channel
Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
Top industry experts have underscored the immediate requirement for healthcare systems and hospitals to respond to severe cost and margin pressures. Close to half of U.S. hospitals ended 2022 in the red... Read more
AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
For healthcare organizations, optimizing operating room (OR) utilization during prime time hours is a complex challenge. Surgeons and clinics face difficulties in finding available slots for booking cases,... Read more
AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
Screening for common cancers like breast, cervix, and prostate cancer relies on relatively simple and highly effective techniques, such as mammograms, Pap smears, and blood tests. These methods have revolutionized... Read morePoint of Care
view channel
Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing
Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Point of Care HIV Test Enables Early Infection Diagnosis for Infants
Early diagnosis and initiation of treatment are crucial for the survival of infants infected with HIV (human immunodeficiency virus). Without treatment, approximately 50% of infants who acquire HIV during... Read more
Whole Blood Rapid Test Aids Assessment of Concussion at Patient's Bedside
In the United States annually, approximately five million individuals seek emergency department care for traumatic brain injuries (TBIs), yet over half of those suspecting a concussion may never get it checked.... Read more
New Generation Glucose Hospital Meter System Ensures Accurate, Interference-Free and Safe Use
A new generation glucose hospital meter system now comes with several features that make hospital glucose testing easier and more secure while continuing to offer accuracy, freedom from interference, and... Read moreBusiness
view channel
Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
Johnson & Johnson (New Brunswick, N.J., USA) and Shockwave Medical (Santa Clara, CA, USA) have entered into a definitive agreement under which Johnson & Johnson will acquire all of Shockwave’s... Read more
